Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04170686 · ClinicalTrials.gov registry record · NA
Acceptability and Efficacy of the Zemedy App for Irritable Bowel Syndrome
A NA study, sponsored by University of Pennsylvania.
- Completed
- Registry status
- NA
- Development phase
- 146
- Enrollment target
NCT04170686: Completed NA study, sponsored by University of Pennsylvania.
NCT04170686 is a NA study that has completed, run by University of Pennsylvania. The registered enrollment target is 146 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04170686, a NA study, has completed, sponsored by University of Pennsylvania.
- COMPLETED
- Registry status
- NA
- Development phase
- 146 participants
- Enrollment target
Study Summary
The purpose of this research is to assess if a new self-help app for IBS is an acceptable and effective intervention for improving the overall quality of life in patients with Irritable Bowel Syndrome.
Interventions
- BEHAVIORAL Zemedy App for Irritable Bowel Syndrome
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 146 participants |
| Start Date | 2019-10-28 |
| Est. Completion | 2020-09-28 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04170686
The ClinicalTrials.gov registry entry for NCT04170686 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 146 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Pennsylvania, which has 1,423 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Zemedy App for Irritable Bowel Syndrome is the first listed.
NCT04170686 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04170686 about?
NCT04170686 is a clinical study titled "Acceptability and Efficacy of the Zemedy App for Irritable Bowel Syndrome". The purpose of this research is to assess if a new self-help app for IBS is an acceptable and effective intervention for improving the overall quality of life in patients with Irritable Bowel Syndrome.
What is the current status of trial NCT04170686?
This trial is currently completed. It is a NA study. The enrollment target is 146 participants. The study started on 2019-10-28. Estimated completion is 2020-09-28.
What interventions are being tested in trial NCT04170686?
The interventions under investigation include: Zemedy App for Irritable Bowel Syndrome (BEHAVIORAL).
Who is sponsoring clinical trial NCT04170686?
This trial is sponsored by University of Pennsylvania, which has 1,423 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.